Cyclophosphamide hydrate

Cyclophosphamide hydrate purchased from MedChemExpress. Usage Cited in: Apoptosis. 2025 Jun;30(5-6):1331-1350. [Abstract]

Customer Validation
Clophosphamide (Cy) (i.p.; the regimens consisting of an initial dose of 50 mg/kg, followed by a daily dose of 10 mg/kg for 14 days) upregulates mitochondrial apoptosis-related proteins (including Cleaved Caspase 9, Cleaved Caspase 3, and BAX) in the ovaries of C57BL/6J mice.

Cyclophosphamide hydrate purchased from MedChemExpress. Usage Cited in: Cell Biol Int. 2025 May 22. [Abstract]

Customer Validation
Using cell viability (MTT) experiments, the DBTRG‐05MG killer dose of Cyclophosphamide (CP; 0–4 mM; 24 h) was determined. We found that the 2 mM had a cell mortality rate of almost 80%.

Cyclophosphamide hydrate purchased from MedChemExpress. Usage Cited in: Cell Biol Int. 2025 May 22. [Abstract]

Customer Validation
Treatments with CAR prevented CP‐induced raising caspases and apoptosis through the inhibition of TRPM2 in DBTRG‐05MG. The CN, CAR (200 μM for 24 h), Cyclophosphamide (CP; 2 mM for 24 h), and their combination (CP + CAR) groups were investigated for apoptosis (A), caspase‐3 (B), caspase‐8 (C), and caspase‐9 (D).

Cyclophosphamide hydrate purchased from MedChemExpress. Usage Cited in: Cell Biol Int. 2025 May 22. [Abstract]

Customer Validation
The Cyclophosphamide (CP; 2 mM for 24 h) increased the proportion of PI‐positive DBTRG‐05MG, whereas the TRPM2 inhibitor (CAR, 200 μM for 24 h) decreased it. A fluorescent Axiocam 702 camera and a ×20 objective inverted microscope (Axio Observer.Z1/7) were used to capture the red (PI), blue (Hoechst), black/white (bright field, BF), overlay, and 2.5D images (A). A 10 μm scale bar was used. PI‐positive (death) cell counts were shown as percentages in columns (B).

Cyclophosphamide hydrate purchased from MedChemExpress. Usage Cited in: Cell Biol Int. 2025 May 22. [Abstract]

Customer Validation
CAR (200 μM for 24 h) reduced Cyclophosphamide (CP; 2 mM for 24 h)‐induced increases in mitochondrial membrane dysfunction (MiDYS) in DBTRG‐05MG. A fluorescent Axiocam 702 camera with a ×20 objective and inverted microscope (Axio Observer.Z1/7) was used to capture the red (MitoTracker), orange (JC‐1), black/white (bright field, BF), overlay, and 2.5D images (A). The bar on the scale was 10 m. The percentages of MiDYS (JC‐1) were shown in columns (B).

Cyclophosphamide hydrate purchased from MedChemExpress. Usage Cited in: Cell Biol Int. 2025 May 22. [Abstract]

Customer Validation
Cyclophosphamide (CP; 2 mM; 24 h)‐induced increases in mROS and iROS were decreased in DBTRG‐05MG by TRPM2 inhibition (CAR, 200 μM for 24 h). The red mROS (MitoSOX), green iROS (DCF), overlay, and 2.5D images were taken using the LSCM equipped with a×20 objective.

Cyclophosphamide hydrate purchased from MedChemExpress. Usage Cited in: Cell Biol Int. 2025 May 22. [Abstract]

Customer Validation
CAR (200 μM for 24 h) incubation reduced the increase in [Ca2+]i in the DBTRG‐05MG caused by Cyclophosphamide (CP; 2 mM for 24 h). After the cells were stained with Fluo‐3 AM (1 μM), they were stimulated with H2O2 (1 mM) for 60–90 s and subsequently inhibited in the LSCM with 200 μM CAR for 60–90 s.

Cyclophosphamide hydrate purchased from MedChemExpress. Usage Cited in: J Clin Invest. 2024 Mar 7;134(10):e172716. [Abstract]

Customer Validation
The given cell lines were treated with 250 nM osimertinib (Osim), 1.25 μM Etoposide (VP-16), 125 nM Doxorubicin (DXR), 5 nM Paclitaxel, 10 μM Cisplatin, 25 μM Carboplatin, 25 nM Gemcitabine, 20 nM 5-Fluorouracil (5-FU), 25 μM Cyclophosphamide, 25 μM Capecitabine, or 10 nM Vincristine alone or in combination for 3 days. Cell numbers were then measured using the SRB assay.

Cyclophosphamide hydrate purchased from MedChemExpress. Usage Cited in: Biochem Pharmacol. 2021 Jan:183:114340. [Abstract]

Customer Validation
Clophosphamide (CYP) (75 mg/kg; i.p., every three days for 7 days) significantly upregulates TRPV1 protein expression in the bladders of naive rats.

Cyclophosphamide hydrate purchased from MedChemExpress. Usage Cited in: Life Sci. 2020 Aug 1;254:117590. [Abstract]

Customer Validation
Cyclophosphamide (75 mg/kg; i.p., every three days for a total of four times). CGA inhibits the MAPK/NF-κB pathway in CYP (Cyclophosphamide)-induced IC (n = 5). Western blotting detects the phosphorylation of p-ERK1/2, p-38, p-JNK, p-NF-κB (p-p65), and p-IκB proteins in the MAPK/NF-κB pathway in each group.